AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
Log in

NYSE:CLXClorox Stock Price, Forecast & News

$223.81
+2.39 (+1.08 %)
(As of 07/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$220.52
Now: $223.81
$224.98
50-Day Range
$197.13
MA: $208.65
$222.16
52-Week Range
$144.12
Now: $223.81
$226.73
Volume1.27 million shs
Average Volume2.02 million shs
Market Capitalization$28.19 billion
P/E Ratio32.82
Dividend Yield1.89%
Beta0.27
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands. It also provides charcoal products under the Kingsford and Match Light brands; bags, wraps, and containers under the Glad brand; cat litter products under the Fresh Step, Scoop Away, and Ever Clean brands; and digestive health products under the RenewLife brand. In addition, the company offers dressings and sauces primarily under the Hidden Valley, KC Masterpiece, Kingsford, and Soy Vay brands; water-filtration systems and filters under the Brita brand; natural personal care products under the Burt's Bees brand; and dietary supplements under the Rainbow Light, Natural Vitality, and Neocell brands. Further, it markets its products under the PinoLuz, Ayudin, Limpido, Clorinda, Poett, Mistolin, Lestoil, Bon Bril, Agua Jane, and Chux brands. The company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force and medical supply distributors. The Clorox Company was founded in 1913 and is headquartered in Oakland, California.
Read More
Clorox logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 1.5Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.98 out of 5 stars


Industry, Sector and Symbol

Industry Polishes & sanitation goods
Sub-IndustryHousehold Products
CUSIP18905410
Phone510-271-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.21 billion
Cash Flow$8.04 per share
Book Value$4.45 per share

Profitability

Net Income$820 million

Miscellaneous

Employees8,800
Market Cap$28.19 billion
Next Earnings Date8/3/2020 (Confirmed)
OptionableOptionable

Receive CLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CLX and its competitors with MarketBeat's FREE daily newsletter.

Clorox (NYSE:CLX) Frequently Asked Questions

How has Clorox's stock been impacted by COVID-19 (Coronavirus)?

Clorox's stock was trading at $169.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CLX shares have increased by 33.2% and is now trading at $225.57. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Clorox?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clorox in the last year. There are currently 3 sell ratings, 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Clorox.

When is Clorox's next earnings date?

Clorox is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Clorox.

How can I listen to Clorox's earnings call?

Clorox will be holding an earnings conference call on Monday, August 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Clorox's earnings last quarter?

Clorox Co (NYSE:CLX) posted its quarterly earnings results on Friday, May, 1st. The company reported $1.89 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.72 by $0.17. The company had revenue of $1.78 billion for the quarter, compared to analysts' expectations of $1.69 billion. Clorox had a return on equity of 147.52% and a net margin of 13.67%. The business's revenue was up 15.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.44 EPS. View Clorox's earnings history.

How often does Clorox pay dividends? What is the dividend yield for Clorox?

Clorox declared a quarterly dividend on Thursday, May 21st. Stockholders of record on Wednesday, July 29th will be paid a dividend of $1.11 per share on Friday, August 14th. This represents a $4.44 annualized dividend and a dividend yield of 1.97%. The ex-dividend date of this dividend is Tuesday, July 28th. This is a positive change from Clorox's previous quarterly dividend of $1.06. View Clorox's dividend history.

What guidance has Clorox issued on next quarter's earnings?

Clorox issued an update on its FY20 earnings guidance on Friday, May, 1st. The company provided earnings per share guidance of $6.70-6.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.57. The company issued revenue guidance of +6-8% yr/yr to ~$6.59-6.71 billion, compared to the consensus revenue estimate of $6.39 billion.

What price target have analysts set for CLX?

13 brokers have issued 12-month price objectives for Clorox's shares. Their forecasts range from $150.00 to $195.00. On average, they expect Clorox's stock price to reach $173.50 in the next year. This suggests that the stock has a possible downside of 23.1%. View analysts' price targets for Clorox.

What are Wall Street analysts saying about Clorox stock?

Here are some recent quotes from research analysts about Clorox stock:
  • 1. Wells Fargo & Co analysts commented, "We were encouraged by mgmt’s confidence in the 2H turnaround and believe issues are isolated within Charcoal/Glad as the rest of the portfolio is performing well (see our note here) That said, while valuation has become more reasonable, we think top-line headwinds are likely to weigh on the stock’s overall narrative, and shares will likely remain range-bound in the near-term until fundamental improvement becomes evident over the next few quarters. Given weak relative top-line performance and near-term challenges, we lower our EPS estimates and maintain our Market Perform rating." (8/1/2019)
  • 2. According to Zacks Investment Research, "Clorox lagged the industry in the past six months owing to ongoing impacts from elevated commodity costs, adverse currency rates as well as increased manufacturing and logistics expenses. Driven by these factors, the company reported dismal earnings and sales in third-quarter fiscal 2019. This marked the first earnings miss after nine straight quarters of beat, while sales lagged estimates for the third time in the last four quarters. Further, the company narrowed sales view for 2019, anticipating a milder cold and flu season, as well as increased promotional activity in the Wipes category. It also expects tariffs to weigh on earnings in 2019. However, the company’s cost savings plans and pricing strategy cushioned results. The company's 2020 Strategy, aimed at bolstering growth of categories and overall market share, also bodes well." (7/29/2019)

Has Clorox been receiving favorable news coverage?

Media stories about CLX stock have been trending negative on Wednesday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Clorox earned a coverage optimism score of -2.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Clorox.

Are investors shorting Clorox?

Clorox saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 11,000,000 shares, a decline of 9.2% from the June 15th total of 12,110,000 shares. Based on an average trading volume of 2,060,000 shares, the short-interest ratio is currently 5.3 days. Approximately 8.8% of the shares of the stock are short sold. View Clorox's Current Options Chain.

Who are some of Clorox's key competitors?

What other stocks do shareholders of Clorox own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Clorox investors own include Johnson & Johnson (JNJ), AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Walt Disney (DIS), Procter & Gamble (PG), NVIDIA (NVDA), Cisco Systems (CSCO), Starbucks (SBUX) and Home Depot (HD).

Who are Clorox's key executives?

Clorox's management team includes the following people:
  • Mr. Benno O. Dorer, Chairman & CEO (Age 55)
  • Mr. Kevin B. Jacobsen, Exec. VP & CFO (Age 52)
  • Ms. Linda Rendle, Exec. VP of Strategy & Operations (Age 41)
  • Ms. Laura Stein, Exec. VP of Corp. Affairs & Gen. Counsel (Age 57)
  • Mr. Stephen M. Robb, Advisor (Age 54)

What is Clorox's stock symbol?

Clorox trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLX."

Who are Clorox's major shareholders?

Clorox's stock is owned by many different institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (0.11%), State of Alaska Department of Revenue (0.07%), Envestnet Asset Management Inc. (0.06%), DNB Asset Management AS (0.01%), First National Bank of Mount Dora Trust Investment Services (0.01%) and OmniStar Financial Group Inc. (0.01%). Company insiders that own Clorox stock include A D David Mackay, Andrew J Mowery, Benno O Dorer, Dawn C Willoughby, Denise Garner, Diego J Barral, Jeff Baker, Jon M Balousek, Kevin B Jacobsen, Laura Stein, Linda J Rendle, Matthew T Laszlo, Michael R Costello and William S Bailey. View institutional ownership trends for Clorox.

Which institutional investors are selling Clorox stock?

CLX stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Confluence Investment Management LLC, OmniStar Financial Group Inc., Martin Capital Partners LLC, Park National Corp OH, Symphony Financial Ltd. Co., M&R Capital Management Inc., and Town & Country Bank & Trust CO dba First Bankers Trust CO. Company insiders that have sold Clorox company stock in the last year include A D David Mackay, Andrew J Mowery, Benno O Dorer, Denise Garner, Diego J Barral, Jeff Baker, Kevin B Jacobsen, Michael R Costello, and William S Bailey. View insider buying and selling activity for Clorox.

Which institutional investors are buying Clorox stock?

CLX stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Fulton Bank N. A., First PREMIER Bank, Clarius Group LLC, Triangle Securities Wealth Management, Bangor Savings Bank, DNB Asset Management AS, and Livforsakringsbolaget Skandia Omsesidigt. View insider buying and selling activity for Clorox.

How do I buy shares of Clorox?

Shares of CLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Clorox's stock price today?

One share of CLX stock can currently be purchased for approximately $225.57.

How big of a company is Clorox?

Clorox has a market capitalization of $28.41 billion and generates $6.21 billion in revenue each year. The company earns $820 million in net income (profit) each year or $6.32 on an earnings per share basis. Clorox employs 8,800 workers across the globe.

What is Clorox's official website?

The official website for Clorox is www.thecloroxcompany.com.

How can I contact Clorox?

Clorox's mailing address is 1221 BROADWAY, OAKLAND CA, 94612. The company can be reached via phone at 510-271-7000 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.